Poniard Pharmaceuticals
(OTC) PARD
Poniard Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$16.04M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-403.60 (Low)
Dividend
$0.00
Beta (Volatility)
-403.60 (Low)
Price
$0.00
Volume
8
Open
$0.00
Price
$0.00
Volume
8
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-403.60 (Low)
Price
$0.00
Volume
8
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
PARD News
10 Stocks to Shake the Market
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Poniard Pharmaceuticals
PARD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-3%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
1.50M
Volume
8
Avg. Volume
3.667
Financials (TTM)
Gross Profit
$0.00
Operating Income
$27.96M
EBITDA
$25.02M
Operating Cash Flow
$24.28M
Capital Expenditure
$7.00K
Free Cash Flow
$24.28M
Cash & ST Invst.
$4.33M
Total Debt
$1.57M
Poniard Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
7
N/A
Net Income
$3.77M
+41.5%
EBITDA
$3.44M
+38.9%
Quarterly Fundamentals
Net Cash
$344.00K
-96.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.64M
-75.1%
Short Term Debt
$0.00
-100.0%
Return on Assets
-2.58%
N/A
Return on Invested Capital
-2.79%
N/A
Free Cash Flow
$1.71M
+56.0%
Operating Cash Flow
$1.71M
+55.9%